HOST DEFENSE MECHANISMS AGAINST ALPHAVIRUS ENCEPHALITIS
Project Number1K08AI001217-01
Contact PI/Project LeaderLEVINE, BETH C
Awardee OrganizationCOLUMBIA UNIV NEW YORK MORNINGSIDE
Description
Abstract Text
The primary objective of this proposal is to investigate the mechanisms
of host defense that are important for recovery from acute viral
infections of the CNS, using SIN encephalitis as a model system. This
investigation will provide new insights into virus-host interactions and
will thereby provide a biologic framework for the development of new
therapeutic antiviral strategies. This proposal will focus on
understanding the mechanisms by which MAbs to the SIN E2 envelope
glycoprotein restrict SIN gene expression in neurons. Based on
preliminary findings demonstrating that the E2 envelope glycoprotein
upregulates gene expression in neuroblastoma cells and that anti-E2 MAbs
that restrict SIN replication enter virally infected neurons, this
research proposal will investigate two principal hypotheses: (1) E2
regulates SIN gene expression and anti-E2 MAbs inhibit SIN replication
by altering this regulatory effect; and (2) anti-E2 MAbs act
intracellulary to inhibit SIN replication. To investigate the first
hypothesis, this proposal will analyze (1) the effects of mutations at
amino acid position 55 on the regulation of SIN gene expression in
neurons and nonneuronal cells; (2) the role of the transmembrane and
cytoplasmic domains of E2 in the regulation of SIN gene expression; (3)
the effects of anti-E2 MAbs on E2-mediated upregulation of SIN gene
expression; and (4) the role of the cytoplasmic domain of E2 in anti-E2
MAb-mediated inhibition of SIN gene expression. To investigate the
second hypothesis, recombinant SIN/immunoglobulin (Ig) gene chimeras will
be engineered to express intracellular anti-E2 MAbs in different cellular
compartments and the effects of expression of anti-E2 MAbs in different
neuronal compartments on SIN replication will be determined.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
049179401
UEI
F4N1QNPB95M4
Project Start Date
01-December-1993
Project End Date
30-November-1996
Budget Start Date
01-December-1993
Budget End Date
30-November-1994
Project Funding Information for 1994
Total Funding
$93,690
Direct Costs
$86,750
Indirect Costs
$6,940
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Allergy and Infectious Diseases
$93,690
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K08AI001217-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K08AI001217-01
Patents
No Patents information available for 1K08AI001217-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K08AI001217-01
Clinical Studies
No Clinical Studies information available for 1K08AI001217-01
News and More
Related News Releases
No news release information available for 1K08AI001217-01
History
No Historical information available for 1K08AI001217-01
Similar Projects
No Similar Projects information available for 1K08AI001217-01